RxDoctor Payments Data

Michael Richards

Pediatrics · Minneapolis, MNNPI 1699741652

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Octapharma USA, Inc.. That places this record below the midpoint for pediatrics clinicians in MN, where the typical reported total is $64.

$55in general payments, 2019–2025

Across 1 payment — averaging $54.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Octapharma USA, Inc.$55
$1,342,923in research payments, 2019–2025

Across 128 payments — averaging $10,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$1.2M
  • Merck$73K
  • Incyte Corporation$43K
  • Gilead$20K
  • Pfizer$3K

What the payments were for

  • Food & beverage$55100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Octapharma USA, Inc.1$55

How this compares

$55 in reported general payments places this provider in the 45th percentile of 397 pediatrics providers in Minnesota.

See all pediatrics providers in Minnesota →

Other pediatrics in Minneapolis

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →